Efficacy of Simbrinza and Rocklatan vs Cosopt and Latanoprost
Efficacy and Tolerability of Simbrinza and Rocklatan vs. Cosopt
Prairie Eye Center
70 participants
May 14, 2025
INTERVENTIONAL
Conditions
Summary
A randomized, multi-site, parallel-group, prospective study of patients who are adults with a diagnosis of mild to moderate open-angle glaucoma (OAG), currently on an on-label use of combination topical medication of Cosopt and Latanoprost for a minimum of 1 month.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
brinzolamide and brimonidine tartrate
netarsudil and latanoprost
dorzolamide hydrochloride and timolol maleate
Latanoprost
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06883123